Tag: biosimilars
Future of Global Generic Markets: Predictions and Trends
Explore the future of the global generic drugs market, covering the shift to biosimilars, the rise of pharmerging nations, and supply chain challenges shaping healthcare affordability.
Read More
Future Economic Trends: Forecasts for Generic Drug Markets
Generic drugs are set to dominate global healthcare by 2030, driven by patent expirations, biosimilars, and cost pressures. Learn how India and China are reshaping supply, why biosimilars are growing fastest, and what this means for patient access and healthcare systems.
Read More